NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cothera Bioscience

Cothera Bioscience

Private
San Mateo, CaliforniaHealthcare & Life Scienceshttps://cotherabio.com/

Last Round

Series B

Dec 23, 2020

Total Funding Raised

$35M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cothera Bioscience is a biotechnology company that develops targeted cancer therapies for previously undruggable targets, leveraging a platform based on synthetic lethality and protein degradation.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Clinical Trials, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

oncology therapeuticsundruggable targetssmall molecule drugsclinical-stage biotechtranslational medicineprotein degradationMYC inhibitorsynthetic lethalityprecision oncologyKRAS inhibitorCDK9 inhibitordrug discovery platformconditional reprogramminghigh-content screeningglioma treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cothera Bioscience Comps

Public and private peers based on sector, stage, and business model.

Cothera Bioscience comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cothera Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 23, 2020
Series AJul 1, 2017

Cothera Bioscience Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 12, 2026

    Monthly visitors increased 1194% from 68 to 880.

  • Jan 22, 2026

    Monthly visitors grew 56% MoM.

Cothera Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cothera Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cothera Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Mateo, California
Employee Range4
Year Founded2019
Last FundingDec 23, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.